Expression and significance of DNA topoisomerase I (topo I) in small cell lung cancer / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 124-126, 2007.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-255707
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the expression and its significance of DNA topoisomerase I (Topo I) in small cell lung cancer (SCLC).</p><p><b>METHODS</b>Topo I expression was detected by immunohistochemical S-P technique on 50 cases of SCLC and 12 cases of normal lung tissues.</p><p><b>RESULTS</b>The total positive rate of Topo I in normal lung tissue was 25.0% (3/12) and 78.0% (39/50) in SCLC. The expression of Topo I does not correlate with age, gender, smoking, tumor size and tumor site (P > 0.05), but significantly correlated with lymph node metastasis and clinical stage (P <0.05).</p><p><b>CONCLUSION</b>High Topo I expression is a rationale indication of Topo I inhibitor treatment of malignancies. It should be possible to predict anti-tumor drug sensitivity by assessment of Topo I expression and help to improve the therapeutic efficacy for cancer patients.</p>
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Immunohistochemistry
/
Carcinoma, Small Cell
/
DNA Topoisomerases, Type I
/
Lung Neoplasms
/
Lymphatic Metastasis
/
Metabolism
/
Methods
/
Neoplasm Staging
Limits:
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Oncology
Year:
2007
Document type:
Article